- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Partial volume correction for Lu-177-PSMA SPECT ; volume:11 ; number:1 ; day:12 ; month:11 ; year:2024 ; pages:1-15 ; date:12.2024
EJNMMI Physics ; 11, Heft 1 (12.11.2024), 1-15, 12.2024
- Classification
-
Recht
- Creator
-
Liu, Yibin
Lu, Zhonglin
Chen, Gefei
Shi, Kuangyu
Mok, Greta S. P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40658-024-00697-1
- URN
-
urn:nbn:de:101:1-2501292105300.536235267036
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Yibin
- Lu, Zhonglin
- Chen, Gefei
- Shi, Kuangyu
- Mok, Greta S. P.
- SpringerLink (Online service)
Other Objects (12)
![Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer](/assets/placeholder/searchResultMediaUnknown.png)
Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
Anatomy-based correction of kidney PVE on $$^177}\text{Lu}$$ 177 Lu SPECT images
An intrapatient dosimetry comparison of 177 Lu-rhPSMA-10.1 and 177 Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer
Comparison of a 3D CZT and conventional SPECT/CT system for quantitative Lu-177 SPECT imaging
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Hematotoxicity and nephrotoxicity in prostate cancer patients undergoing radioligand therapy with [\(^177}\)Lu]Lu-PSMA I&T
Klinische Beurteilung der Wirksamkeit und Toxizität der Lu-177-PSMA-Ligandentherapie bei kastrationsresistentem Prostatakarzinom
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Urinary excretion kinetics of [177Lu]Lu-PSMA-617
Retrospektive Analyse von Lu-177-PSMA-617-Therapien bei Patienten mit metastasiertem Prostatakarzinom am Universitätsklinikum Regensburg
Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
Anatomy-based correction of kidney PVE on $$^177}\text{Lu}$$ 177 Lu SPECT images
An intrapatient dosimetry comparison of 177 Lu-rhPSMA-10.1 and 177 Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer
Comparison of a 3D CZT and conventional SPECT/CT system for quantitative Lu-177 SPECT imaging
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Hematotoxicity and nephrotoxicity in prostate cancer patients undergoing radioligand therapy with [\(^177}\)Lu]Lu-PSMA I&T
Klinische Beurteilung der Wirksamkeit und Toxizität der Lu-177-PSMA-Ligandentherapie bei kastrationsresistentem Prostatakarzinom
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Urinary excretion kinetics of [177Lu]Lu-PSMA-617
Retrospektive Analyse von Lu-177-PSMA-617-Therapien bei Patienten mit metastasiertem Prostatakarzinom am Universitätsklinikum Regensburg
Matched-pair analysis of [\(^177}\)Lu]Lu-PSMA I&T and [\(^177}\)Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CT
Anatomy-based correction of kidney PVE on $$^177}\text{Lu}$$ 177 Lu SPECT images
An intrapatient dosimetry comparison of 177 Lu-rhPSMA-10.1 and 177 Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer
Comparison of a 3D CZT and conventional SPECT/CT system for quantitative Lu-177 SPECT imaging
Biodistribution and dosimetry for combined [177Lu]Lu-PSMA-I&T/[225Ac]Ac-PSMA-I&T therapy using multi-isotope quantitative SPECT imaging
Hematotoxicity and nephrotoxicity in prostate cancer patients undergoing radioligand therapy with [\(^177}\)Lu]Lu-PSMA I&T
Klinische Beurteilung der Wirksamkeit und Toxizität der Lu-177-PSMA-Ligandentherapie bei kastrationsresistentem Prostatakarzinom
Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Correction to: Dual Radionuclide Therapy: The Synergistic Effects of [161Tb]Tb-PSMA and [177Lu]Lu-PSMA in Advanced Prostate Cancer Post [177Lu]Lu-PSMA Failure
Urinary excretion kinetics of [177Lu]Lu-PSMA-617